Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

JCV serology in time: 3 years of follow-up.
Inhaled Sargramostim Induces Resolution of Pulmonary Alveolar Proteinosis in Lysinuric Protein Intolerance.
Listeria rhombencephalitis mimicking a demyelinating event in an immunocompetent young patient.
Physician compensation for industry-sponsored clinical trials in multiple sclerosis influences patient trust.
Sometimes less is more in multiple sclerosis drug switching.
Schwann cell proliferation and differentiation that is induced by ferulic acid through MEK1/ERK1/2 signalling promotes peripheral nerve remyelination following crush injury in rats.
Role of Sonic Hedgehog Signaling in Oligodendrocyte Differentiation.
Can we stop immunomodulatory treatments in secondary progressive multiple sclerosis?
Grey:white matter ratio at diagnosis and the risk of 10-year multiple sclerosis progression.
Multiple sclerosis: The resolving lesion revealed.
Managing the Quality of Life in Patients with Multiple Sclerosis: A Literature Review.
Sex-based differences in autoimmune diseases.
Epigenetic Modifications and Therapy in Multiple Sclerosis.
The dilemma of diabetes in chronic inflammatory demyelinating polyneuropathy.
Alpha-tocopherol ameliorates experimental autoimmune encephalomyelitis through the regulation of Th1 cells.
Combined effects of transferrin and thyroid hormone during oligodendrogenesis In vitro.
The Dual-specificity phosphatase Dusp15 is regulated by Sox10 and Myrf in Myelinating Oligodendrocytes.
Prevalence and Causes of Paralysis-United States, 2013.
ERK1/2 Activation in Preexisting Oligodendrocytes of Adult Mice Drives New Myelin Synthesis and Enhanced CNS Function.
Self-reported quality of life in multiple sclerosis patients: preliminary results based on the Polish MS Registry.
Rituximab for treating multiple sclerosis: Off-label but on target.
The role of anti-aquaporin 4 antibody in the conversion of acute brainstem syndrome to neuromyelitis optica.
Involvement of the IL-1 system in experimental autoimmune encephalomyelitis and multiple sclerosis: Breaking the vicious cycle between IL-1β and GM-CSF.
Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (The PATH Study): study protocol for a randomized controlled trial.
[Transverse myelitis associated with toxocariasis and the importance of locally produced antibodies for diagnosis].

Pages